NCT03613467 is a clinical trial of VATS lobectomy in Non-small Cell Lung Cancer, sponsored by Tang-Du Hospital.

Who is sponsoring NCT03613467?

NCT03613467 is sponsored by Tang-Du Hospital.

What drugs are being tested in NCT03613467?

Interventions in NCT03613467: VATS lobectomy, Thoracotomy lobectomy.

What condition does NCT03613467 study?

NCT03613467 studies Non-small Cell Lung Cancer.

Is NCT03613467 still recruiting?

NCT03613467 is currently completed. Last updated 9 August 2018.

Last reviewed 2018-08-09 · How we verify

NCT03613467

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Is Video-assisted Thoracoscopic Lobectomy a Clinical Alternative for Surgically Resectable Pathologic N2 NSCLC Patients

Completed Last updated 9 August 2018

What this trial tests

trial testing VATS lobectomy in Non-small Cell Lung Cancer in 2,145 participants. Completed in 6 July 2018.

Timeline

4 July 2018

Primary endpoint
4 July 2018

6 July 2018

Quick facts

Lead sponsor	Tang-Du Hospital
Status	Completed
Study type	OBSERVATIONAL
Enrollment	2,145
Start date	4 July 2018
Primary completion	4 July 2018
Estimated completion	6 July 2018
Sites	10 locations across China

Drugs / interventions tested

VATS lobectomy
Thoracotomy lobectomy

Conditions studied

Non-small Cell Lung Cancer — all drugs for Non-small Cell Lung Cancer →

Sponsor

Tang-Du Hospital

Who can join

18 and older, any sex, with Non-small Cell Lung Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study was designed to compare the safety and effectiveness of vedio-assisted thoracoscopic lobectomy with open lobectomy for patients with surgically resectable pathologic N2 non-small cell lung cancer

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Video-assisted thoracoscopic surgery lobectomy might be a feasible alternative for surgically resectable pathological N2 non-small cell lung cancer patients.
Zhao J, Li W, Wang M, Liu L, et al · · 2021 · cited 5× · PMID 33205914 · DOI 10.1111/1759-7714.13680

Verify or expand the search:

Other trials of VATS lobectomy

Trials testing the same drug.

NCT03134534 — Robot-assisted vs VATS Lobectomy for NSCLC · NA · completed
NCT04799509 — Assessment of the 90-day Mortality Risk Score After VATS Lobectomy · completed
NCT04511091 — Studio Osservazionale Retrospettivo Uneventful Vatslobectomy: Caratteristiche Cliniche All'Interno Del Registro Vats Gro · completed

Other recruiting trials for Non-small Cell Lung Cancer

Currently open trials in the same condition.

NCT07431827 — MK-3475A±Calderasib (MK-1084) in Completely Resected Stage IIA-IIIB (N2) KRAS G12Cm NSCLC (MK-1084-013) · Phase 3 · recruiting
NCT05987956 — Pharmacogenomics IND EXEMPT SNP Clinical Trial - Alectinib and Single Nucleotide Polymorphisms · Phase 2, PHASE3 · active not recruiting
NCT07195695 — Beamion LUNG-3: A Study to Test Whether Zongertinib Helps People With Surgically Removed, Non-small Cell Lung Cancer Wit · Phase 3 · recruiting
NCT06686771 — Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer · Phase 3 · recruiting
NCT06477055 — The Recurrence Gene Profiles of Adjuvant Osimertinib Therapy in Resected Non-Small-Cell Lung Cancer · recruiting

Other Tang-Du Hospital trials

Trials by the same sponsor.

NCT07528235 — An Open-Label, Dose-Escalation Study on the Safety, Tolerability and Preliminary Efficacy for Preventing SAP by Intraven · Phase 1 · not yet recruiting
NCT07516522 — Intra-arterial Methylprednisolone After Endovascular Thrombectomy · Phase 2 · recruiting
NCT07354061 — Neoadjuvant Therapy With Ensartinib Combined With Chemotherapy for ALK-positive Non - Small Cell Lung Cancer (NSCLC) · Phase 1, PHASE2 · recruiting
NCT07327736 — Anesthesia Comparison in Early-stage Small NSCLC: A Multicenter RCT · NA · not yet recruiting
NCT07452601 — Time-of-Day of Immunotherapy Infusion in Neoadjuvant Immunochemotherapy for Thoracic ESCC · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03613467 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Tang-Du Hospital
Last refreshed: 9 August 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03613467.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing